Sally Lettis - Concepedia

Author

Sally Lettis

GlaxoSmithKline (United Kingdom)ORCID

Also Known As

Lettis, S, Lettis, Sally, S Lettis, S. Donoghue, S. LETTIS, S. Lettis, SALLY LETTIS, Sally Lettis

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University of Michigan Research Triangle Park Foundation GlaxoSmithKline (United States)University of Alabama at Birmingham

About

Sally Lettis is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	626
2	Allergy	2	2	582
3	Health Sciences	1	1	15
4	Biochemistry	1	1	15
5	Diabetes	1	1	15

Sally Lettis

Publications

Citations

H-Index

Page 1

	Year	Citations
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials Mark T. Dransfield, Jean Bourbeau, Paul Jones, The Lancet Respiratory Medicine AllergyAdvanced Lung DiseasePulmonary MedicineVilanterol Versus VilanterolMedicine	2013	357
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD Ian Pavord, Sally Lettis, Nicholas Locantore, Thorax	2015	315
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease David A. Lipson, Courtney Crim, Gerard J. Criner, American Journal of Respiratory and Critical Care Medicine	2020	237
Blood eosinophils as a marker of response to inhaled corticosteroids in COPD Neil Barnes, Raj Kumar Sharma, Sally Lettis, European Respiratory Journal	2016	236
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial Steven Pascoe, Neil Barnes, Guy Brusselle, The Lancet Respiratory Medicine AllergyAdvanced Lung DiseaseBlood EosinophilsImpact TrialEosinophilic Disorder	2019	225
Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD Courtney Crim, Mark T. Dransfield, Jean Bourbeau, Annals of the American Thoracic Society	2014	154
The Efficacy and Safety of the Novel Long-Acting β2 Agonist Vilanterol in Patients With COPD Nicola A. Hanania, Gregory Feldman, W. Zachgo, CHEST Journal	2012	105
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD James L. Kreindler, Michael L. Watkins, Sally Lettis, BMJ Open Respiratory Research	2016	42
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial MeiLan K. Han, Gerard J. Criner, Mark T. Dransfield, American Journal of Respiratory and Critical Care Medicine	2020	39
Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly Type 2 diabetic patients Sudhesh Kumar, Åge Prange, Jan Schulze, Diabetic Medicine	1998	38

Page 1